Showing results (71-80 of 408) with videos related to
Sort By:
Pageof 41
Proceedings of the National Academy of Sciences of the United States of America|June 8, 2001
Identification and characterization of a lysosomal transporter for small neutral amino acidsC Sagné, C Agulhon, P Ravassard, et al.Molecular Pharmacology|September 1, 1992
Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporterB Giros, S el Mestikawy, N Godinot, et al.The Journal of Biological Chemistry|September 1, 1995
Carboxypeptidase A isoforms produced by distinct genes or alternative splicing in brain and other extrapancreatic tissuesE Normant, C Gros, J C SchwartzPsychopharmacology|October 20, 1976
Climbing behavior induced by apomorphine in mice: a simple test for the study of dopamine receptors in striatumP Protais, J Costentin, J C SchwartzNaunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1991
Evidence that histamine H3 receptors are involved in the control of gastric acid secretion in the conscious catG Coruzzi, G Bertaccini, J C SchwartzNeuroscience|January 1, 1989
Role of a serine endopeptidase in the hydrolysis of exogenous cholecystokinin by brain slicesA Camus, C Rose, J C SchwartzProceedings of the National Academy of Sciences of the United States of America|November 1, 1988
A serine peptidase responsible for the inactivation of endogenous cholecystokinin in brainC Rose, A Camus, J C SchwartzJournal of Neurochemistry|April 1, 1987
Properties and localization of the sulfate-activating system in rat brainF Brion, J C Schwartz, F VargasEuropean Journal of Pharmacology|April 10, 1990
Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11)C Gros, A Souque, J C SchwartzEuropean Journal of Pharmacology|March 19, 1999
Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptorsS Perachon, J C Schwartz, P SokoloffPageof 41